معرفی
Lorenzo Galluzzi is an Assistant Professor of Dermatology at Yale School of Medicine, with an adjunct appointment. His research integrates cell death mechanisms, cancer immunology, and immuno-oncology to uncover therapeutic targets for refractory cancers.
Education: While specific degrees aren’t listed, his prolific publication record in high-impact journals (e.g., Cell Death & Differentiation, Nature Immunology) indicates extensive training in molecular biology and oncology.
Research Interests:
- Cell Death Pathways: Apoptosis, necroptosis, and autophagy in cancer and aging.
- Immuno-Oncology: Mechanisms of immune evasion and response to therapies like checkpoint inhibitors.
- Mitochondrial Regulation: Role of VDAC2 and CYPD in cancer immunity.
- Radiotherapy-Immunotherapy Synergy: Enhancing anti-tumor immunity via radiation.
Recent Work Trends: His 2025 publications emphasize spatial transcriptomics in triple-negative breast cancer, metabolic switches in cell death, and the immunological impact of ATM deficiency. These studies bridge basic science and clinical applications, particularly in immunotherapy resistance.
Awards: No specific awards are listed, but his leadership in international conferences (e.g., ImmunoRad) and editorial roles suggest recognition in the field.
Collaborations & Labs: Works with teams at Yale and Weill Cornell Medicine, evidenced by co-authored papers and his Cornell email. His ORCID (0000-0003-2257-8500) links to further collaborative outputs.
